Clinical Trials Directory

Trials / Terminated

TerminatedNCT05405764

The CONFUCIUS Oral Protein Supplementation Trial

CONvalescence of FUntional Outcomes After ICU Stay by Oral Protein Supplementation

Status
Terminated
Phase
N/A
Study type
Interventional
Enrollment
15 (actual)
Sponsor
ARH van Zanten · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Study the effect of 6-weeks porcine protein supplementation vs isocaloric comparator (carbohydrate) on functional outcomes in post ICU-patients. Patients will be included at ICU discharge. Included patients will receive the supplements twice daily (morning and afternoon), starting at the first day at the general ward. To the best of our knowledge, a study on protein supplementation in the post-ICU period to address its effect on functional outcomes is lacking.

Detailed description

Patients discharged from the Intensive Care Unit frequently suffer from Post Intensive Care Syndrome. This syndrome is characterized by muscle weakness and physical disabilities besides neurocognitive and psychological disturbances. Studies have shown that protein requirements in the post-ICU phase are often not met. Furthermore, protein supplementation in other patient groups have shown beneficial effects. However, a study on protein supplementation during the post-ICU period is lacking. This study aims to investigate the effect of protein supplementation on functional outcomes in post-ICU patients.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTPorcine protein supplementPorcine protein supplementation
DIETARY_SUPPLEMENTControl product maltodextrin supplementMaltodextrin supplementation

Timeline

Start date
2022-04-19
Primary completion
2024-09-24
Completion
2024-09-24
First posted
2022-06-06
Last updated
2024-09-25

Locations

1 site across 1 country: Netherlands

Source: ClinicalTrials.gov record NCT05405764. Inclusion in this directory is not an endorsement.